These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12787824)

  • 1. NF449, a novel picomolar potency antagonist at human P2X1 receptors.
    Hülsmann M; Nickel P; Kassack M; Schmalzing G; Lambrecht G; Markwardt F
    Eur J Pharmacol; 2003 May; 470(1-2):1-7. PubMed ID: 12787824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
    Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
    Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
    J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors.
    Seyffert C; Schmalzing G; Markwardt F
    Curr Top Med Chem; 2004; 4(16):1719-30. PubMed ID: 15579104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
    Braun K; Rettinger J; Ganso M; Kassack M; Hildebrandt C; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):285-90. PubMed ID: 11521173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors.
    Klapperstück M; Büttner C; Nickel P; Schmalzing G; Lambrecht G; Markwardt F
    Eur J Pharmacol; 2000 Jan; 387(3):245-52. PubMed ID: 10650169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
    Hausmann R; Rettinger J; Gerevich Z; Meis S; Kassack MU; Illes P; Lambrecht G; Schmalzing G
    Mol Pharmacol; 2006 Jun; 69(6):2058-67. PubMed ID: 16551782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain lysines and suramin block of P2X1 receptors.
    Sim JA; Broomhead HE; North RA
    J Biol Chem; 2008 Oct; 283(44):29841-6. PubMed ID: 18765669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
    Farmer LK; Schmid R; Evans RJ
    J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.
    Rettinger J; Schmalzing G; Damer S; Müller G; Nickel P; Lambrecht G
    Neuropharmacology; 2000 Aug; 39(11):2044-53. PubMed ID: 10963748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue.
    Alexander K; Niforatos W; Bianchi B; Burgard EC; Lynch KJ; Kowaluk EA; Jarvis MF; van Biesen T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1135-42. PubMed ID: 10565834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder.
    Kennedy C; Tasker PN; Gallacher G; Westfall TD
    J Neurosci; 2007 Jan; 27(4):845-51. PubMed ID: 17251425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional evidence of distinct ATP activation sites at the human P2X(7) receptor.
    Klapperstück M; Büttner C; Schmalzing G; Markwardt F
    J Physiol; 2001 Jul; 534(Pt 1):25-35. PubMed ID: 11432989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
    Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors.
    Soto F; Lambrecht G; Nickel P; Stühmer W; Busch AE
    Neuropharmacology; 1999 Jan; 38(1):141-9. PubMed ID: 10193905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
    Kassack MU; Braun K; Ganso M; Ullmann H; Nickel P; Böing B; Müller G; Lambrecht G
    Eur J Med Chem; 2004 Apr; 39(4):345-57. PubMed ID: 15072843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of zinc on human and rat P2X2 receptors.
    Tittle RK; Hume RI
    J Neurosci; 2008 Oct; 28(44):11131-40. PubMed ID: 18971456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
    El-Ajouz S; Ray D; Allsopp RC; Evans RJ
    Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and functional characterization of human P2X(2) receptors.
    Lynch KJ; Touma E; Niforatos W; Kage KL; Burgard EC; van Biesen T; Kowaluk EA; Jarvis MF
    Mol Pharmacol; 1999 Dec; 56(6):1171-81. PubMed ID: 10570044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations.
    Rettinger J; Schmalzing G
    J Gen Physiol; 2003 May; 121(5):451-61. PubMed ID: 12719485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.